Abstract
In the past two decades important steps have been taken towards the understanding of the molecular pathogeneses that underlie many malignant diseases. Studies in cancer genetics have identified loci which play central roles in the regulation of cell proliferation and differentiation and whose mutations are associated with tumorigenesis. Functional characterizations of these loci often demonstrated that they encode factors, which are directly involved in transcriptional regulation of gene expression. The last two decades have also seen some remarkable advances in the treatment of cancer, particularly hematopoietic malignancies, where acute promyelocytic leukemia (APL) has led the way both in treatment innovation and in the understanding of the molecular events underlying the disease process. The demonstration that APL could respond to differentiation therapy with all-transretinoic acid (ATRA) as a sole therapeutic agent has made this relatively rare hematopoietic malignancy a model disease. Interest in APL was further enhanced by the discovery that the retinoic acid receptor-α (RARα) locus, a member of the nuclear receptor (NR) superfamily, was reciprocally translocated to a gene of unknown function called PML (for Promyelocytic Leukemia) leading to expression of PML-RARa and RARa-PML fusion proteins. This article will review the current understanding of the role that the NR corepressors play in the molecular pathogenesis of APL and address recent data directly implicating these molecules in processes associated with the development of more common myeloid and lymphoid malignancies.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alland L, Muhle R, Hou H Jr, Potes J, Chin L, Schreiber-Agus N, DePinho RA (1997) Role for N-CoRand histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49 - 55
Amatruda T, Koeffler H (1986) Retinoids and cells of the hematopoietic system. In: Sherman M (ed) Retinoids and Cell Differentiation. CRC Press, Boca Raton, Florida, pp 79 - 103
Archer SY, Hodin RA (1999) Histone acetylation and cancer. Curr Opin Genet Dev 9: 171 - 174
Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP (1997) Groucho-dependent and -independent repression activities of Runt domain proteins. Mol Cell Biol 17: 5581 - 5587
Bannister AJ, Kouzarides T (1996) The CBP co-activator is a histone acetyltransferase. Nature 384: 641 - 643
Baur EV, Zechel C, Heery D, Heine MJS, Gamier JM, Vivat V, Ledouarin B, Gronemeyer H, Chambon P, Losson R (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors msugl and Tifl. Embo J 15: 110 - 124
Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H, Lanotte M (1999) RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. Embo J 18: 7011 - 7018
Bishop JM (1986) Oncogenes as hormone receptors. Nature 321: 112 - 113
Brown ’D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM (1997) A PML-RARa transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 94: 2551 - 2556
Caligiuri MA, Strout MP, Gilliland DG (1997) Molecular biology of acute myeloid leukemia. Semin Oncol 24: 32 - 44
Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954 Chen A, Licht JD, Wu Y, Hellinger N, Scher W, Waxman S (1994) Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood84: 2122 - 2129
Chen G, Fernandez J, Mische S, Courey AJ (1999) A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 13: 22182230
Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454 - 457
Chen JY, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P, Gronemeyer H (1996) Two distinct actions of retinoid-receptor ligands. Nature 382: 819 - 822
Chen Z, Brand NJ, Chen A, Chen S-J, Tong J-H, Wang Z-Y, Waxman S, Zelent A (1993) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-a locus due to a variant t(11;17) translocation associated with acute promeylocytic leukaemia. Embo J 12: 1161 - 1167
Chen Z, Guidez F, Rousselot P, Agadir A, Chen S-J, Wang Z-Y, Degos L, Zelent A, Waxman S, Chomienne C (1994) PLZF-RARa fusion proteins generated from the variant t(11;17)(g23;21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci USA 91: 1178 - 1182
Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ (1999) Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. Proc Natl Acad Sci USA 96: 6318 - 6323
Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, Licht J, Waxman S, Chen Z, GluecksohnWaelsch S, Krumlauf R, Zelent A (1995) Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. Proc Natl Acad Sci USA 92: 2249 - 2253
Damm K, Thompson CC, Evans RM (1989) Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339: 593 - 597
David G, Alland L, Hong S-H, Wong C-W, DePinho R, Dejean A (1998) Histone deacetylase associated with mSin3A mediates repression by the promyelocytic leukemia-associated PLZF protein. Oncogene 16: 2549 - 2556
de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RARa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675 - 684
Demetri GD, Fletcher CD, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM, Singer S (1999) Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96: 3951 - 3956
Dhordain P, Albagli O, Lin JN, Ansieau S, Quief S, Leutz A, Kerckaert J-P, Evans RM, Leprince D (1997) Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci USA 94: 10762 - 10767
Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE (1998) Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 92: 1172 - 1183
Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong H-J, Wang Z-Y, Licht J, Waxman S, Chomienne C, Zelent A, Chen S-J (1996) Amino-terminal protein-protein interaction motif ( POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-a fusion protein. Proc Natl Acad Sci USA 93: 3624-3629
Doucas V, Tini M, Egan DA, Evans RM (1999) Modulation of CREB binding protein function by the promyelocytic ( PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci USA 96: 2627-2632
Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333 - 343
Early E, Moore MA, Kakizuka A, Nason Burchenal K, Martin P, Evans RM, Dmitrovsky E (1996) Transgenic expression of PML-RARalpha impairs myelopoiesis. Proc Natl Acad Sci USA 93: 7900 - 7904
Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E (1998) Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci USA 95: 2795 - 2800
Engel I, Murre C (1999) Transcription factors in hematopoiesis. Curr Opin Genet Dev 9:575-579 Enver T, Greaves M (1998) Loops, lineage, and leukemia. Cell 94: 9 - 12
Erickson P, Gao J, Chang K-S, Look T, Whisemant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AMLI/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80: 1825-1831
Fears S, Gavin M, Zhang DE, Hetherington C, BenDavid Y, Rowley JD, Nucifora G (1997) Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proc Natl Acad Sci USA 94: 1949 - 1954
Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR, Hiebert SW (1999) Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein. Mol Cell Biol 19: 6566 - 6574
Fisher AL, Caudy M (1998) Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev 12: 1931 - 1940
Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M (1998) The partner gene of AMLI in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91: 4028 - 4037
Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 18: 7185 - 7191
Glass CK, Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121 - 141
Goddard AD, Borrow J, Freemont P, Solomon E (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254: 1371 - 1374
Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG (1995) Fusion of the TEL gene on 12p13 to the AMLI gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci, USA 92: 4917-4921
Grignani F, DeMatteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391: 815 - 818
Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara FF, Bonci D, Nervi C, Pelicci PG (1999) Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Oncogene 18: 6313 - 6321
Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E (1997) Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 90: 48764885
Grozinger CM, Hassig CA, Schreiber SL (1999) Three proteins define a class of human histone deacetylases related to yeast Hdalp. Proc Natl Acad Sci USA 96: 4868 - 4873
Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389: 349 - 352
Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A (1998) Reduced retinoic acid-sensitivities of nuclear receptor co-repressor binding to PML- and PLZF-RARa underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91: 2634 - 2642
Guidez F, Petrie K, Ford AM, Lu H, Bennett CA, MacGregor A, Hannemann J, Ito Y, Ghysdael J, Greaves M, Wiedemann L, Zelent A (1999) Childhood leukemia associated TEL-AML1 oncoprotein binds nuclear receptor co-repressor N-CoR and functions as a histone deacetylase dependent transcriptional repressor. Blood 94: 693a
Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341 - 347
Hassig CA, Schreiber SA (1998) Nuclear histone acetylases and deacetylases and transcriptional regulation. Curr Opin Chem Biol 1: 300 - 308
He L-Z, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP (1998) Distinct interactions of PML-RARa with transcriptional co-repressors determine differential responses to retinoic acid in APL. Nat Genet 18: 126 135
He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP (1997) Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 94: 5302 - 5307
Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43 - 48
Hernandez-Munain C, Krangel MS (1994) Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors. Mol Cell Biol 14: 473 - 483
Hiebert SW, Downing JR, Lenny N, Meyers S (1996) Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO. Curr Top Microbiol Immunol 211: 253 - 258
Hiebert SW, Sun W, Davies JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussel MF, Gilliland DG, Lenny N, Meyers S (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16: 1349 - 1355
Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht J (1999) A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 94: 3737 - 3747
Hodges RE, Sauberlich HE, Canham JE, Wallace DL, Rucker RB, Mejia LA, Mohanram M (1978) Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 31: 876 - 885
Hong SH, David G, Wong CW, Dejean A, Privalsky ML (1997) SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor a ( RARa) and PLZF-RARa oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94: 9028-9033
Horlein Ai, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld M (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397 - 404
Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK (1997) Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 94: 1074 - 1079
Kadonaga JT (1998) Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92: 307 - 313
Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dimitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell 66: 663-674
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403 - 414
Kastner P, Brand N, Krust A, Leroy P, Mendelsohn C, Petkovich M, Zelent A, Chambon P (1991) Retinoic acid nuclear receptors. In: Hinchliffe JRea (ed) Developmental patterning of the vertebrate limb. Plenum Press, New York, pp 75 88
Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. Embo J 11: 629 - 642
Kerckaert J-P, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C (1993) LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5: 66 - 70
Kijima M, Yoshida M, Sugita K, Horinouchi S, Beppu T (1993) Trapoxin, an antitumor cyclic tetra-peptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 268: 22429 - 22435
Kingston RE, Bunker CA, Imbalzano AN (1996) Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 10: 905 - 920
Kitabayashi I, Yokoyama A, Shimizu K, Ohki M (1998) Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. Embo J 17: 2994 - 3004
Koken MH, Daniel MT, Gianni M, Zelent A, Licht J, Buzyn A, Minard P, Degos L, Varet B, de The H (1999) Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(g23;g21) APL patient. Oncogene 18: 1113 - 1118
Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Clavo F, Chomienne C, Degos L, Puvion E, de The H (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. Embo J 13: 1073 - 1083
Koken MHM, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JHS, Zhu J, Dong S, Chen S-J, Chen Z, Tan CC, Licht J, Waxman S, de The H, Zelent A (1997) Leukemia associated retinoic acid receptor a fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci USA 94: 10255-10260
Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN (1997) Histone deacetylasesassociated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89: 349 - 356
LaMorte VJ, Dyck JA, Ochs RL, Evans RM (1998) Localization of nascent RNA and CREB bindingprotein with the PML-containing nuclear body. Proc Natl Acad Sci USA 95: 4991 - 4996
Lee DY, Hayes JJ, Pruss D, Wolfe AP (1993) A positive role for histone acetylation in transcriptionfactor access to nucleosomal DNA. Cell 72: 73 - 84
Leid M, Kastner P, Chambon P (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17: 427 - 433
Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J-Y, Staub A, Gamier J-M, Mader S, Chambon P (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377 - 395
Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y (1998) Transcriptional repression by AMLI and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci USA 95: 11590 - 11595
Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, DeBlasio A, Miller W Jr, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Vail A, Cortes J, Kantarjian H, Waxman S (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85: 1083 - 1094
Lin R, Nagy L, Inoue S, Shao W, Miller W, Jr Evans R (1998) Role of histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811 - 814
Liu P, Tarie SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ (1993) Fusion between transcription factor CBFß/PEBP213 and a myosin heavy chain in acute myeloid leukemia. Science 261: 1041 - 1044
Look A (1997) Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064 Lutterbach B, Hou Y, Durst KL, Hiebert SW (1999) The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc Natl Acad Sci USA 96: 12822 - 12827
Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW (2000) A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275: 651 - 656
Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18: 7176 - 7184
Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6: 329 - 344
Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850 Mehta K, McQueen T, Manshouri T, Andreeff M, Collins S, Albitar M (1997) Involvement of retinoic acid receptor-a-mediated signaling pathway in induction of CD38 cell-surface antigen. Blood 89: 3607 - 3614
Meyers S, Downing JR, Hiebert SW (1993) Identification of AML-1 and (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13: 6336 - 6345
Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. Embo J 18: 5099 - 5107
Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AMLI-EVI-1 fusion gene in t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. Embo J 13: 504 - 510
Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M (1991) t(8;21) breakpoints in chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88: 10431 - 10434
Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373 - 380
Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K (1993) Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194: 314 - 331
Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N, Tani K, Hibino H, Asano S, Mucenski ML, Ito Y, Noda T, Satake M (1998) AMLI(-/-) embryos do not express certain hematopoiesisrelated gene transcripts including those of the PU.1 gene. Oncogene 17: 2287 - 2293
Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR (1996) AMLI, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321 - 330
Onate SA, Tsai SY, Tsai MJ, Omalley BW (1995) Sequence and Characterization Of a Coactivator For the Steroid-Hormone Receptor Superfamily. Science 270: 1354 - 1357
Orkin SH (1996) Development of the hematopoietic system. Curr Opin Genet Dev 6: 597 - 602
Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y (1999) Biallelic and heterozygous point mutations in the runt domain of the AMLI/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93: 1817 - 1824
Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG (1991) Structure and origin of the acute promyelocytic leukemia myl/RARa eDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6: 1285 - 1292
Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P (1993) PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. Embo J 12: 3171 - 3182
Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H (1998) PML induces a novel caspase-independent death process. Nat Genet 20: 259 - 265
Redner R, Rush E, Schlesinger K, Pollock S, Watkins S (1997) The t(5;17) APL fusion protein NPMRAR does not alter PML localization. Blood 90: 1431
Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87: 882 - 886
Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A (1995) Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86: 4544 4552
Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 95: 3003 - 3007
Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA (1996) Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA 93: 5705 - 5708
Robertson KA, Emami B, Collins SJ (1992) Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80: 1885 - 1889
Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Pastier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AMLI gene fusion. Blood 85: 36623670
Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611 - 617
Roulston D, Espinosa R, Nucifora G, Larson RA, Le Beau MM, Rowley JD (1998) CBFA2 (AMLI) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92: 2879 - 2885
Rowley JD (1998) The critical role of chromosome translocations in human leukemias. Ann Rev Genet 32: 495 - 519
Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD (1998) The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol 18: 5533 - 5545
Shivdasani RA, Orkin SH (1996) The transcriptional control of hematopoiesis. Blood 87: 4025 - 4039
Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM, Gilliland DG (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23: 166 - 175
Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai M-J, O’Malley BW (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194 - 198
Stone RM, Mayer RJ (1990) The unique aspects of acute promyelocytic leukaemia. J Clin Oncol 8: 1913 - 1921
Takahashi A, Satake M, Yamaguchi-Iwai Y, Bae S, Lu J, Maruyama M, Zhang Y, Oka H, Arai N, Arai K, Ito Y (1995) Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promote activity by AMLI-related transcription factor, PEBP2. Blood 86: 607 - 616
Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H (1995) Dual functions of the AML 1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol 15: 2383 - 2392
Taunton J, Hassig CA, Schreiber SL (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408 - 411
Tenen DG, Hromas R, Licht JD, Zhang DE (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90: 489 - 519
Tsai S, Collins SJ (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90: 7153 - 7157
Uchida H, Zhang J, Nimer SD (1997) AMLIA and AMLIB can transactivate the human IL-3 promoter. J Immunol 158: 2251 - 2258
Vettese-Dadey M, Walter P, Chen H, Juan LJ, Workman JL (1994) Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosome cores. Mol Cell Biol 14: 970 - 981
Vidali G, Boffa LC, Bradbury EM, Allfrey VG (1978) Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 75: 2239 - 2243
Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H (1996) TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. Embo J 15: 3667 - 3675
Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th’ng J, Han J, Yang XJ (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19: 7816 - 7827
Wang H, Stillman DJ (1993) Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol Cell Biol 13: 1805 - 1814
Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM (1998) ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDACI complex. Proc Natl Acad Sci USA 95: 10860 - 10865
Wang J, Saunthararajah Y, Redner RL, Liu JM (1999) Inhibitors of histone deacetylase relieve ETOmediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res 59: 27662769
Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw Boris A, Binder M, Marin Padilla M, Sharpe AH, Speck NA (1996) The CBFß subunit is essential for CBFa2 (AML1) function in vivo. Cell 87:697-708Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA (1993) Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13: 3324 - 3339
Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, CordonCardo C, Grosveld F, Pandolfi PP (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279: 1547 - 1551
Warrell RP Jr (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies and implications. Blood 82: 1949 - 1953
Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90: 1621 - 1625
Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARa in acute promyelocytic leukemia cells. Cell 76: 345 - 356
Wells RA, Catzavelos C, Kamel-Reid S (1997) Fusion of retinoic acid receptor a to NuMA, the mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet 17: 109 - 113
Wolbach SB, Howe PR (1925) Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 42: 753 - 777
Wong CW, Privalsky ML (1998) Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol 18: 5500 - 5510
Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262: 747 - 750
Yoshida M, Horinouchi S, Beppu T (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17: 423 - 430
Zelent A, Krust A, Petkovich M, Kastner P, Chambon P (1989) Cloning of murine a and 13 retinoic acid receptors and a novel receptor y predominantly expressed in skin. Nature 339: 714 - 717
Zelent A, Zhu J, Lanotte M, Gallagher R, Waxman S, Heyworth CM, Enver T (1997) Differential expression of retinoid receptors during multilineage differentiation of haemopoietic progenitor cells-role of the RARa2 isoform in normal granulopoiesis and leukaemia. Blood 90: 186
Zenke M, Munoz A, Sap J, Vennstrom B, Beug H (1990) v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61: 1035 - 1049
Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP (1999) A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet 23: 287 - 295
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Guidez, F., Zelent, A. (2001). Role of Nuclear Receptor Corepressors in Leukemogenesis. In: Privalsky, M.L. (eds) Transcriptional Corepressors: Mediators of Eukaryotic Gene Repression. Current Topics in Microbiology and Immunology, vol 254. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10595-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-10595-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-08709-7
Online ISBN: 978-3-662-10595-5
eBook Packages: Springer Book Archive